Full Pediatric Labeling Is Lacking For One Third Of Orphan Drugs, US FDA Finds
The past three years have seen an increase in number of orphan drug labels containing appropriate pediatric information.
You may also be interested in...
PhRMA asks FDA to consider expiration of pediatric exclusivity in requesting pediatric clinical trials; AbbVie describes eight-year effort to begin enrollment in Humira pediatric ulcerative colitis study.
Pink Sheet infographic illustrates new drug approval trends and highlights from the past decade at the US FDA.